Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. In a search for silver linings...
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting marketing authorisation approval under exceptional circumstances for Nezglyal (leriglitazone) as...
How can biotechs be investor ready? Key takeaways from BIO International and DIA China 2026. Read More
Argenx said Monday it would buy Forte Biosciences to expand its immunology pipeline, continuing the sector’s acquisition run, as even midsize companies hunt for pick-up targets. ...
Investment and a maturing talent base have propelled Denmark ahead of its Nordic peers, drawing Swedish companies and exposing regional gaps in capital and scale.
StockWatch: Axiom CEO Explains Plans for Hong Kong IPO
Safety will be the key determinant of in vivo CAR T therapies, according to H.C. Wainwright’s Mitchel Kapoor, who noted that convenience and efficacy won’t be...
Summit, Merck must navigate new regulatory terrain in China-first cancer landscape
Nature Biotechnology, Published online: 27 July 2026; doi:10.1038/s41587-026-03229-7 Polyketide synthases are engineered for the production of sustainable plastics.
Post Content